264 related articles for article (PubMed ID: 18436392)
21. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
22. Fever of unknown origin: the role of 18F-FDG PET/CT.
Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
[TBL] [Abstract][Full Text] [Related]
23. Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Aukema TS; Straver ME; Peeters MJ; Russell NS; Gilhuijs KG; Vogel WV; Rutgers EJ; Olmos RA
Eur J Cancer; 2010 Dec; 46(18):3205-10. PubMed ID: 20719497
[TBL] [Abstract][Full Text] [Related]
24. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer.
Kato H; Kimura H; Nakajima M; Sakai M; Sano A; Tanaka N; Inose T; Faried A; Saito K; Ieta K; Sohda M; Fukai Y; Miyazaki T; Masuda N; Fukuchi M; Ojima H; Tsukada K; Oriuchi N; Endo K; Kuwano H
Oncol Rep; 2008 Oct; 20(4):857-62. PubMed ID: 18813827
[TBL] [Abstract][Full Text] [Related]
25. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
[TBL] [Abstract][Full Text] [Related]
26. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Kim SJ; Lee TH; Kim IJ; Kim YK
Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
[TBL] [Abstract][Full Text] [Related]
27. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
[TBL] [Abstract][Full Text] [Related]
28. Disseminated tuberculosis masquerading as metastatic breast carcinoma on PET-CT.
Das CJ; Kumar R; Balakrishnan VB; Chawla M; Malhotra A
Clin Nucl Med; 2008 May; 33(5):359-61. PubMed ID: 18431158
[TBL] [Abstract][Full Text] [Related]
29. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G
Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492
[TBL] [Abstract][Full Text] [Related]
30. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.
Li J; Kuehl H; Grabellus F; Müller SP; Radunz S; Antoch G; Nadalin S; Broelsch CE; Gerken G; Paul A; Kaiser GM
J Surg Oncol; 2008 Nov; 98(6):438-43. PubMed ID: 18767120
[TBL] [Abstract][Full Text] [Related]
31. F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers.
Haug AR; Schmidt GP; Klingenstein A; Heinemann V; Stieber P; Priebe M; la Fougère C; Becker C; Hahn K; Tiling R
J Comput Assist Tomogr; 2007; 31(4):629-34. PubMed ID: 17882045
[TBL] [Abstract][Full Text] [Related]
32. 18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: a multicentre study.
Grassetto G; Fornasiero A; Otello D; Bonciarelli G; Rossi E; Nashimben O; Minicozzi AM; Crepaldi G; Pasini F; Facci E; Mandoliti G; Marzola MC; Al-Nahhas A; Rubello D
Eur J Radiol; 2011 Dec; 80(3):828-33. PubMed ID: 20547020
[TBL] [Abstract][Full Text] [Related]
33. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
McDonough PB; Jones DR; Shen KR; Northup PG; Galysh RL; Hernandez A; White GE; Kahaleh M; Shami VM
Am J Gastroenterol; 2008 Mar; 103(3):570-4. PubMed ID: 17941963
[TBL] [Abstract][Full Text] [Related]
34. [Role of PET-CT with 18-FDG in the management of UADT squamous-cell carcinomas: a retrospective study of 43 cases].
Ricard AS; Gindre A; Laurentjoye M; Fernandez P; Guyot M; Demeaux H; Siberchicot F; Majoufre-Lefebvre C
Rev Stomatol Chir Maxillofac; 2008 Apr; 109(2):86-90. PubMed ID: 18207477
[TBL] [Abstract][Full Text] [Related]
35. [The role of / 18FDG PET/CT for the initial staging and therapy in primary breast cancer].
Inokuchi M; Furukawa H; Kayahara M; Ohta T; Kawashima H; Taki J; Kinuya S
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2526-31. PubMed ID: 20009451
[TBL] [Abstract][Full Text] [Related]
36. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
[TBL] [Abstract][Full Text] [Related]
37. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
Zhang X; Wu F; Han P
Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
[TBL] [Abstract][Full Text] [Related]
38. Additional value of F-18 FDG PET/CT for initial staging in breast cancer with clinically negative axillary nodes.
Jeong YJ; Kang DY; Yoon HJ; Son HJ
Breast Cancer Res Treat; 2014 May; 145(1):137-42. PubMed ID: 24682676
[TBL] [Abstract][Full Text] [Related]
39. Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II-III breast cancer patients treated with neoadjuvant chemotherapy.
Koolen BB; Valdés Olmos RA; Vogel WV; Vrancken Peeters MJ; Rodenhuis S; Rutgers EJ; Elkhuizen PH
Breast Cancer Res Treat; 2013 Sep; 141(2):249-54. PubMed ID: 24002735
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET/CT in the evaluation of POEMS syndrome.
Albertí MA; Martinez-Yélamos S; Fernandez A; Vidaller A; Narváez JA; Cano LM; Gamez C; Martinez-Matos JA
Eur J Radiol; 2010 Nov; 76(2):180-2. PubMed ID: 19581061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
